VANDA PHARMACEUTICALS INC.
Revenue Breakdown
| Fiscal Year | Licensing and Collaboration Revenue | HETLIOZ Product Sales | Fanapt Product Sales | PONVORY Product Sales |
|---|---|---|---|---|
| FY2014 | $0 | $13.5M | $51.1M | $0 |
| FY2015 | $0 | $44.3M | $57.0M | $0 |
| FY2016 | $0 | $71.7M | $74.2M | $0 |
| FY2017 | $0 | $90.1M | $75.0M | $0 |
| FY2018 | $0 | $114.7M | $81.5M | $0 |
| FY2019 | $0 | $144.1M | $83.1M | $0 |
| FY2020 | $0 | $161.4M | $86.8M | $0 |
| FY2021 | $0 | $173.3M | $95.1M | $0 |
| FY2022 | $0 | $159.7M | $94.7M | $0 |
| FY2023 | $0 | $100.2M | $91.8M | $550.0K |